Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$766M |
| 2 |
Adobe
ADBE
|
$529M |
| 3 |
Merck
MRK
|
$463M |
| 4 |
Tesla
TSLA
|
$359M |
| 5 |
AGN
Allergan plc
AGN
|
$339M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$714M |
| 2 |
Gilead Sciences
GILD
|
$600M |
| 3 |
Perrigo
PRGO
|
$585M |
| 4 |
EMC
EMC CORPORATION
EMC
|
$448M |
| 5 |
Morgan Stanley
MS
|
$423M |
Sector Composition
| 1 | Healthcare | 17.95% |
| 2 | Consumer Discretionary | 15% |
| 3 | Communication Services | 10.58% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
American Eagle Outfitters
AEO
$3.26B
| – | – |
-873,876
| Closed | -$12.2M |
|
|
AMRN
702
Amarin Corp
AMRN
$317M
| – | – |
-256,171
| Closed | -$32.4M |
|
703
Angi Inc
ANGI
$811M
| – | – |
-3,722
| Closed | -$837K |
|
704
Broadcom
AVGO
$1.58T
| – | – |
-7,904,030
| Closed | -$34.1M |
|
705
Conagra Brands
CAG
$9.23B
| – | – |
-114,194
| Closed | -$2.7M |
|
706
C.H. Robinson
CHRW
$14.9B
| – | – |
-1,288,824
| Closed | -$76.8M |
|
707
Charles River Laboratories
CRL
$8.07B
| – | – |
-6,037
| Closed | -$279K |
|
708
Danaher
DHR
$143B
| – | – |
-16,449
| Closed | -$766K |
|
709
Fastenal
FAST
$55.1B
| – | – |
-999,736
| Closed | -$12.6M |
|
710
Fortress Biotech
FBIO
$110M
| – | – |
-109,660
| Closed | -$11.5M |
|
711
Green Dot
GDOT
$760M
| – | – |
-12,109
| Closed | -$319K |
|
712
Gen Digital
GEN
$18.2B
| – | – |
-31,235
| Closed | -$773K |
|
713
HUB Group
HUBG
$2.29B
| – | – |
-1,680,038
| Closed | -$33M |
|
714
IBM
IBM
$232B
| – | – |
-13,816
| Closed | -$2.45M |
|
715
iShares Russell 2000 ETF
IWM
$67.8B
| – | – |
0
| – | – |
|
716
Lockheed Martin
LMT
$108B
| – | – |
-25,082
| Closed | -$3.2M |
|
717
LyondellBasell Industries
LYB
$17.7B
| – | – |
-15,831
| Closed | -$1.16M |
|
718
Neurocrine Biosciences
NBIX
$14.3B
| – | – |
-1,642,465
| Closed | -$18.6M |
|
719
Oracle
ORCL
$654B
| – | – |
-100,878
| Closed | -$3.35M |
|
720
Petrobras
PBR
$78.7B
| – | – |
-88,061
| Closed | -$1.36M |
|
721
PG&E
PCG
$33.2B
| – | – |
-661,002
| Closed | -$27M |
|
722
Precigen
PGEN
$1.3B
| – | – |
-235,425
| Closed | -$5.33M |
|
723
Prologis
PLD
$105B
| – | – |
-896,774
| Closed | -$33.7M |
|
|
724
Perrigo
PRGO
$3.12B
| – | – |
-4,744,979
| Closed | -$585M |
|
725
Plus Therapeutics
PSTV
$48.8M
| – | – |
-3
| Closed | -$847K |
|